Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Phase 2 Recruiting
80 enrolled
Personalized NK Cell Therapy in CBT
Phase 2 Recruiting
100 enrolled
Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors
Phase 2 Terminated
9 enrolled 11 charts
BV-AVD-R Treatment Children Hodgkin's Lymphoma
Phase 2 Unknown
44 enrolled
Brentuximab for Newly Diagnosed Hodgkin Disease
Phase 2 Completed
40 enrolled
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
Phase 2 Completed
6 enrolled 10 charts
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas
Phase 2 Completed
50 enrolled 13 charts
Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Phase 2 Completed
73 enrolled 16 charts
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Phase 2 Completed
176 enrolled 18 charts
Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma
Phase 2 Terminated
6 enrolled 14 charts
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
Phase 2 Terminated
4 enrolled 4 charts
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
Phase 2 Completed
51 enrolled 8 charts
Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma
Phase 2 Completed
63 enrolled 12 charts
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Phase 2 Terminated
12 enrolled 12 charts
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
Phase 2 Completed
48 enrolled 12 charts
Rituximab in Treating Patients With Hodgkin's Lymphoma
Phase 2 Completed
39 enrolled 9 charts
Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment
Phase 2 Withdrawn
Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
Phase 2 Completed
39 enrolled
HD0607
Phase 2 Unknown
450 enrolled
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer
Phase 2 Terminated
36 enrolled 16 charts
Rituximab and ABVD for Hodgkin's Patients
Phase 2 Completed
85 enrolled 5 charts
Cellular Therapy With Cord Blood Cells
Phase 2 Completed
31 enrolled 6 charts